A detailed history of Northern Capital Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Northern Capital Management, Inc. holds 1,486 shares of ABBV stock, worth $262,947. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,486
Previous 1,529 2.81%
Holding current value
$262,947
Previous $262,000 11.83%
% of portfolio
0.19%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$163.84 - $199.33 $7,045 - $8,571
-43 Reduced 2.81%
1,486 $293,000
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $28,171 - $32,898
-182 Reduced 10.64%
1,529 $262,000
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $17,100 - $19,484
107 Added 6.67%
1,711 $311,000
Q4 2023

Feb 13, 2024

BUY
$137.6 - $154.97 $412 - $464
3 Added 0.19%
1,604 $248,000
Q3 2023

Oct 27, 2023

SELL
$133.59 - $154.65 $2,271 - $2,629
-17 Reduced 1.05%
1,601 $238,000
Q2 2023

Jul 27, 2023

BUY
$132.51 - $164.9 $397 - $494
3 Added 0.19%
1,618 $217,000
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $433 - $499
3 Added 0.19%
1,615 $257,000
Q4 2022

Feb 07, 2023

SELL
$138.31 - $165.87 $6,500 - $7,795
-47 Reduced 2.83%
1,612 $260,000
Q3 2022

Oct 24, 2022

BUY
$134.21 - $153.93 $402 - $461
3 Added 0.18%
1,659 $223,000
Q2 2022

Aug 02, 2022

SELL
$137.62 - $174.96 $29,725 - $37,791
-216 Reduced 11.54%
1,656 $254,000
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $34,314 - $42,575
260 Added 16.13%
1,872 $303,000
Q4 2021

Jan 13, 2022

BUY
$107.43 - $135.93 $173,177 - $219,119
1,612 New
1,612 $218,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Northern Capital Management, Inc. Portfolio

Follow Northern Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northern Capital Management, Inc. with notifications on news.